NEW YORK (GenomeWeb News) – Microbial biomarker technologies developer Second Genome has undertaken an initiative with American Gut, a multi-partner effort to characterize the microbial diversity of the gut, to study the possible roles the human microbiome may play in type 2 diabetes.

Under the initiative, Second Genome made a donation to American Gut of an undisclosed amount to fund specimen collection for participants who have type 2 diabetes, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.